![]() |
|
|
TS Chen, JP Richie and CA Lang
Department of Pharmacology and Toxicology, University of Louisville, KY 40292.
Our previous finding of a glutathione (GSH) deficiency in aging or senescent mice suggested that a concomitant decrease in detoxification capacity also may occur. To test this, mice at different biological stages of the life span (growth, maturity, aging or senescence) were injected with various doses of acetaminophen (APAP), and GSH depletion and recovery rates were determined. At intervals for 24 hr, samples of blood and other tissues were obtained, processed, and analyzed for reduced GSH, glutathione disulfide (GSSG), cysteine, and cystine using HPLC with dual electrochemical detection. In the uninjected controls, the GSH concentration decreased about 30% in all tissues of the aging mouse, but the GSSG cysteine, and cystine levels were unchanged during the life span. APAP administration depleted liver and lung GSH contents in a dose- and time-dependent manner. Four hr after APAP administration, hepatic GSH levels of all ages had decreased 70-80%. After 24 hr, the GSH levels of the young, growing (3-6 months), and mature (12 months) mice recovered to 94 and 66%, respectively, of the controls. In contrast, the level in aging (31 months) mice rose only 41%, a lower recovery that was correlated with their decreased GSH content. The lungs of old mice also were GSH-deficient but differed from liver, for there was less GSH depletion by APAP and no decrease in GSH recovery. Thus, these findings demonstrate clearly the occurrence of decreased detoxification capacity in the GSH-deficient, aging mouse.
This article has been cited by other articles:
![]() |
L. Cai, Y. Wang, G. Zhou, T. Chen, Y. Song, X. Li, and Y. J. Kang Attenuation by Metallothionein of Early Cardiac Cell Death via Suppression of Mitochondrial Oxidative Stress Results in a Prevention of Diabetic Cardiomyopathy J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1688 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. McKeever, S. A. Lewis, H. A. Smit, P. Burney, J. R. Britton, and P. A. Cassano The Association of Acetaminophen, Aspirin, and Ibuprofen with Respiratory Disease and Lung Function Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 966 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Eneli, K. Sadri, C. Camargo Jr, and R. G. Barr Acetaminophen and the Risk of Asthma: The Epidemiologic and Pathophysiologic Evidence Chest, February 1, 2005; 127(2): 604 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Oz, M. Ray, T. S. Chen, and C. J. McClain Efficacy of a Transforming Growth Factor {beta}2 Containing Nutritional Support Formula in a Murine Model of Inflammatory Bowel Disease J. Am. Coll. Nutr., June 1, 2004; 23(3): 220 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Barr, C. C. Wentowski, G. C. Curhan, S. C. Somers, M. J. Stampfer, J. Schwartz, F. E. Speizer, and C. A. Camargo Jr. Prospective Study of Acetaminophen Use and Newly Diagnosed Asthma among Women Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 836 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
S O Shaheen, R B Newson, A Sherriff, A J Henderson, J E Heron, P G J Burney, J Golding, and the Alspac Study Team Paracetamol use in pregnancy and wheezing in early childhood Thorax, November 1, 2002; 57(11): 958 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Lang, A. Huang, J. A. Ramirez, and M. C. Liu Erythrocytic Glutathione and Plasma Cysteine Status of Human Immunodeficient Patients Experimental Biology and Medicine, October 1, 2001; 226(9): 866 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Lang, A. P. Matheny Jr., W. Mastropaolo, and M. C. Liu Blood Glutathione and Cysteine Concentrations in Twin Children Experimental Biology and Medicine, April 1, 2001; 226(4): 349 - 352. [Abstract] [Full Text] |
||||
![]() |
S. O Shaheen, J. A C Sterne, C. E Songhurst, and P. G J Burney Frequent paracetamol use and asthma in adults Thorax, April 1, 2000; 55(4): 266 - 270. [Abstract] [Full Text] |
||||